Researchers at Johns Hopkins University, supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), have developed a groundbreaking nanoprobe called nanoSABER for improved cancer imaging. This smart nanoprobe infiltrates prostate tumors and emits a signal using Raman spectroscopy, providing precise, single-cell resolution images. The nanoprobe is activated by an enzyme found in aggressive prostate cancer cells, allowing for targeted detection without interference from surrounding tissue. This innovation could potentially revolutionize cancer diagnosis and treatment by offering real-time monitoring of tumor aggressiveness and treatment efficacy. The study, funded by NIBIB, NCI, and NIGMS, represents a significant advancement in cancer imaging technology with promising implications for personalized cancer care.
About the graphics: The graphics used in this highlight were adapted from figures in the publication in Advanced Science and are licensed under the Creative Commons Attribution 4.0 International License.